Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-027329

EVP and Chief Medical Officer sold 5,000 shares at $109.09 ($545,450)

  • EVP and Chief Medical Officer acquired 5,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Bedrosian Camille L · EVP and Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-04-15 Exercise or conversion : show line 1 in the form +5,000 $55.00 $275,000 44,139 D
2021-04-15 Sale : show line 2 in the form −5,000 $109.09 $545,450 39,139 D
Open-market sales · 5,000 sh · avg $109.09 · $545,450

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-04-15 Exercise or conversion : show line 3 in the form Stock Option −5,000 58,000 D
Loading xslF345X03/doc4.xml…